Hu Zhongwu, Wang Yaqin, Wang Yuemei, Zang Bao, Hui Hongxia, You Zhenbing, Wang Xiaowei
Department of Thoracic Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, 223300, PR China.
Department of Thoracic Surgery, Huai'an Hospital Affiliated to Xuzhou Medical University, Huai'an, Jiangsu, 223002, PR China.
Biochem Biophys Res Commun. 2017 Jan 29;483(1):645-651. doi: 10.1016/j.bbrc.2016.12.089. Epub 2016 Dec 18.
Stress-activated protein kinase (SAPK) interacting protein 1 (SIN1) is an essential component of mTORC2. Previous studies have shown that SIN1 is a key regulator of Akt pathway which plays an important role in various pathological conditions including cancer. While its effects and mechanisms on the progression of NSCLC remain unknown. In this study, we report that SIN1 is able to promote the growth and migration of NSCLC cells both in vitro and in vivo. Overexpression of SIN1 promoted A549 and H1299 cells proliferation by both MTT and colony formation assays. Consistently, knockdown of SIN1 inhibited the proliferation of these cells. In transwell assay, overexpression of SIN1 increased the migration of A549 and H1299 cells, while SIN1 knockdown reduced their migration. In a tumor xenograft model, overexpression of SIN1 promoted tumor growth of A549 cells in vivo, while SIN1 knockdown suppresses the tumor growth. We also found a mechanistic link between SIN1 and H3K4me3, H3K4me3 is involved in SIN1 upregulation. Moreover, SIN1 can significantly promote the in vitro migration and invasion of NSCLC cells via induction epithelial mesenchymal transition (EMT) process, which subsequently leads to transcriptional downregulation of epithelial marker E-cadherin and upregulation of mesenchymal markers N-cadherin and Vimentin expression. Together, our results reveal that SIN1 plays an important role in NSCLC and SIN1 is a potential biomarker and a promising target in the treatment of NSCLC.
应激激活蛋白激酶(SAPK)相互作用蛋白1(SIN1)是mTORC2的重要组成部分。先前的研究表明,SIN1是Akt通路的关键调节因子,在包括癌症在内的各种病理状况中发挥重要作用。然而,其对非小细胞肺癌(NSCLC)进展的影响和机制仍不清楚。在本研究中,我们报告SIN1在体外和体内均能促进NSCLC细胞的生长和迁移。通过MTT和集落形成实验,SIN1的过表达促进了A549和H1299细胞的增殖。同样,敲低SIN1可抑制这些细胞的增殖。在Transwell实验中,SIN1的过表达增加了A549和H1299细胞的迁移,而敲低SIN1则减少了它们的迁移。在肿瘤异种移植模型中,SIN1的过表达促进了体内A549细胞的肿瘤生长,而敲低SIN1则抑制了肿瘤生长。我们还发现了SIN1与H3K4me3之间的机制联系,H3K4me3参与了SIN1的上调。此外,SIN1可通过诱导上皮-间质转化(EMT)过程显著促进NSCLC细胞的体外迁移和侵袭,这随后导致上皮标志物E-钙黏蛋白的转录下调以及间质标志物N-钙黏蛋白和波形蛋白表达的上调。总之,我们的结果表明SIN1在NSCLC中起重要作用,并且SIN1是一种潜在的生物标志物以及治疗NSCLC的有前景的靶点。